USA Alzheimer's Disease Diagnostic Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Alzheimer's Disease Diagnostic Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Early-onset Alzheimer's Market Performance (Volume)
  • 2.1.2 Late-onset Alzheimer's Market Performance (Volume)
  • 2.1.3 Familial Alzheimer's Disease Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Early-onset Alzheimer's Market Performance (Value)
  • 2.1.2 Late-onset Alzheimer's Market Performance (Value)
  • 2.1.3 Familial Alzheimer's Disease Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Clinics Market Performance (Volume)
  • 3.1.2 Hospitals Market Performance (Volume)
  • 3.1.3 Diagnostic Centers Market Performance (Volume)
  • 3.1.4 Others Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Eli Lilly and Company (UK)
  • 4.1.1 Eli Lilly and Company (UK) Profiles
  • 4.1.2 Eli Lilly and Company (UK) Product Information
  • 4.1.3 Eli Lilly and Company (UK) Alzheimer's Disease Diagnostic Business Performance
  • 4.1.4 Eli Lilly and Company (UK) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.2 TauRx (Republic of Singapore)
  • 4.2.1 TauRx (Republic of Singapore) Profiles
  • 4.2.2 TauRx (Republic of Singapore) Product Information
  • 4.2.3 TauRx (Republic of Singapore) Alzheimer's Disease Diagnostic Business Performance
  • 4.2.4 TauRx (Republic of Singapore) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.3 Alector LLC (US)
  • 4.3.1 Alector LLC (US) Profiles
  • 4.3.2 Alector LLC (US) Product Information
  • 4.3.3 Alector LLC (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.3.4 Alector LLC (US) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.4 Accera (US)
  • 4.4.1 Accera (US) Profiles
  • 4.4.2 Accera (US) Product Information
  • 4.4.3 Accera (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.4.4 Accera (US) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.5 Treventis Corporation (US)
  • 4.5.1 Treventis Corporation (US) Profiles
  • 4.5.2 Treventis Corporation (US) Product Information
  • 4.5.3 Treventis Corporation (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.5.4 Treventis Corporation (US) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.6 Neuro-Bio Ltd (UK)
  • 4.6.1 Neuro-Bio Ltd (UK) Profiles
  • 4.6.2 Neuro-Bio Ltd (UK) Product Information
  • 4.6.3 Neuro-Bio Ltd (UK) Alzheimer's Disease Diagnostic Business Performance
  • 4.6.4 Neuro-Bio Ltd (UK) Alzheimer's Disease Diagnostic Business Development and Market Status
• 4.7 Cognition Therapeutics (US)
  • 4.7.1 Cognition Therapeutics (US) Profiles
  • 4.7.2 Cognition Therapeutics (US) Product Information
  • 4.7.3 Cognition Therapeutics (US) Alzheimer's Disease Diagnostic Business Performance
  • 4.7.4 Cognition Therapeutics (US) Alzheimer's Disease Diagnostic Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 USA Alzheimer's Disease Diagnostic Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 USA Alzheimer's Disease Diagnostic Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 USA Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 USA Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Northeast Market Performance for Manufacturers
  • 6.1.1 Northeast Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Northeast Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Northeast Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Northeast Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Midwest Market Performance for Manufacturers
  • 6.2.1 Midwest Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Midwest Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Midwest Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Midwest Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Market Performance for Manufacturers
  • 6.3.1 South Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 West Market Performance for Manufacturers
  • 6.4.1 West Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 West Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 West Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 West Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration

7 USA Alzheimer's Disease Diagnostic Market Performance (Sales Point)

• 7.1 USA Alzheimer's Disease Diagnostic Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 USA Alzheimer's Disease Diagnostic Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 USA Alzheimer's Disease Diagnostic Price (USD/Unit) by Regions 2013-2018
• 7.4 USA Alzheimer's Disease Diagnostic Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 USA Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Northeast Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Midwest Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 West Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Clinics Industry
• 11.2 Hospitals Industry
• 11.3 Diagnostic Centers Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 USA Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 USA Alzheimer's Disease Diagnostic Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Northeast Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Midwest Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 West Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Early-onset Alzheimer's Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Late-onset Alzheimer's Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Familial Alzheimer's Disease Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Clinics Sales and and Growth Rate 2019-2024
  • 12.4.3 Hospitals Sales and and Growth Rate 2019-2024
  • 12.4.4 Diagnostic Centers Sales and and Growth Rate 2019-2024
  • 12.4.5 Others Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 USA Alzheimer's Disease Diagnostic Price (USD/Unit) Trend 2019-2024
  • 12.5.2 USA Alzheimer's Disease Diagnostic Gross Profit Trend 2019-2024

13 Conclusion